Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4923
Source ID: NCT00500955
Associated Drug: Rosiglitazone
Title: Rosiglitazone on Microalbuminuria in Type 2 Diabetics
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Rosiglitazone
Outcome Measures: Primary: The primary efficacy endpoint was percent change from baseline in ACR after 32 weeks of treatment., 32 Weeks | Secondary: Secondary efficacy endpoints included change from baseline (visit 3) at week 32 (visit 7) in the following: serum TGF, creatinine clearance (calculated), PAI-1, CRP, IL-6, vWF, sVCAM, fibrinogen, TNF alpha, ET-1, heart rate and blood pressure, 32 Weeks
Sponsor/Collaborators: Sponsor: GlaxoSmithKline
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 336
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2000-04
Completion Date: 2004-06
Results First Posted:
Last Update Posted: 2016-09-15
Locations: GSK Investigational Site, Birmingham, Alabama, 35211, United States|GSK Investigational Site, Tempe, Arizona, 85282, United States|GSK Investigational Site, Fullerton, California, 92835, United States|GSK Investigational Site, Long Beach, California, 90806, United States|GSK Investigational Site, Mission Viejo, California, 92691, United States|GSK Investigational Site, Pasadena, California, 91105, United States|GSK Investigational Site, Redwood City, California, 94062, United States|GSK Investigational Site, San Diego, California, 92108, United States|GSK Investigational Site, San Diego, California, 92128, United States|GSK Investigational Site, Santa Barbara, California, 93105, United States|GSK Investigational Site, Tustin, California, 92780, United States|GSK Investigational Site, Ukiah, California, 95482, United States|GSK Investigational Site, Denver, Colorado, 80209, United States|GSK Investigational Site, Denver, Colorado, 80220, United States|GSK Investigational Site, New Britain, Connecticut, 06050, United States|GSK Investigational Site, Norwalk, Connecticut, 06850, United States|GSK Investigational Site, Newark, Delaware, 19713, United States|GSK Investigational Site, Jacksonville, Florida, 32204, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Winter Park, Florida, 32789, United States|GSK Investigational Site, Blue Ridge, Georgia, 30513, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, Peoria, Illinois, 61615, United States|GSK Investigational Site, Indianapolis, Indiana, 46201, United States|GSK Investigational Site, South Bend, Indiana, 46601, United States|GSK Investigational Site, Slidell, Louisiana, 70458, United States|GSK Investigational Site, Baltimore, Maryland, 21208, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Springfield, Massachusetts, 01199, United States|GSK Investigational Site, Royal Oak, Michigan, 48073, United States|GSK Investigational Site, Brooklyn Center, Minnesota, 55430, United States|GSK Investigational Site, St. Louis, Missouri, 63141, United States|GSK Investigational Site, Henderson, Nevada, 89014, United States|GSK Investigational Site, Las Vegas, Nevada, 89103, United States|GSK Investigational Site, Albuquerque, New Mexico, 87106, United States|GSK Investigational Site, Albany, New York, 12206, United States|GSK Investigational Site, Binghamton, New York, 13903, United States|GSK Investigational Site, Endwell, New York, 13760, United States|GSK Investigational Site, New York, New York, 10010, United States|GSK Investigational Site, Portland, Oregon, 97232, United States|GSK Investigational Site, Hermitage, Pennsylvania, 16148, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19124, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15221, United States|GSK Investigational Site, Columbia, South Carolina, 29201, United States|GSK Investigational Site, Beaumont, Texas, 77701, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Houston, Texas, 77027, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Houston, Texas, 77074, United States|GSK Investigational Site, San Antonio, Texas, 78207, United States|GSK Investigational Site, San Antonio, Texas, 78237, United States|GSK Investigational Site, Richmond, Virginia, 23249, United States|GSK Investigational Site, Edmonds, Washington, 98026, United States|GSK Investigational Site, Spokane, Washington, 99204, United States|GSK Investigational Site, Madison, Wisconsin, 53792, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53209-0996, United States|GSK Investigational Site, Vienna, A-1030, Austria|GSK Investigational Site, Vienna, A-1090, Austria|GSK Investigational Site, Vienna, A-1140, Austria|GSK Investigational Site, Vancouver, British Columbia, V6Z 2K8, Canada|GSK Investigational Site, Winnipeg, Manitoba, R3A 1R9, Canada|GSK Investigational Site, North Bay, Ontario, P1B 2H3, Canada|GSK Investigational Site, Ottawa, Ontario, K1H 7W9, Canada|GSK Investigational Site, Peterborough, Ontario, K9J 7B3, Canada|GSK Investigational Site, Smiths Falls, Ontario, K7A 2H6, Canada|GSK Investigational Site, Toronto, Ontario, M5C 2T2, Canada|GSK Investigational Site, Laval, Quebec, H7T 2P5, Canada|GSK Investigational Site, Montreal, Quebec, H1T 2M4, Canada|GSK Investigational Site, Sainte-Foy, Quebec, G1V 4G2, Canada|GSK Investigational Site, Santiago, Región Metro De Santiago, 7510605, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, Chile|GSK Investigational Site, Viña del Mar, Valparaíso, Chile|GSK Investigational Site, Koenigsfeld, Baden-Wuerttemberg, 78126, Germany|GSK Investigational Site, Unterschneidheim, Baden-Wuerttemberg, 73485, Germany|GSK Investigational Site, Grafing, Bayern, 85567, Germany|GSK Investigational Site, Frankfurt, Hessen, 60596, Germany|GSK Investigational Site, Borna, Sachsen, 04552, Germany|GSK Investigational Site, Delitzsch, Sachsen, 04509, Germany|GSK Investigational Site, Dresden, Sachsen, 01307, Germany|GSK Investigational Site, Goerlitz, Sachsen, 02826, Germany|GSK Investigational Site, Leipzig, Sachsen, 04107, Germany|GSK Investigational Site, Apolda, Thueringen, 99510, Germany|GSK Investigational Site, Jelgava, LV 3001, Latvia|GSK Investigational Site, Riga, LV 1006, Latvia|GSK Investigational Site, Riga, LV1002, Latvia|GSK Investigational Site, Riga, LV1079, Latvia|GSK Investigational Site, Talsi, LV 3201, Latvia|GSK Investigational Site, Valmiera, LV 4201, Latvia|GSK Investigational Site, Guadalajara, Jalisco, 44340, Mexico|GSK Investigational Site, Durango, 3400, Mexico|GSK Investigational Site, Mexico, 14080, Mexico|GSK Investigational Site, Amersfoort, 3818 ES, Netherlands|GSK Investigational Site, Leiden, 2331 JE, Netherlands|GSK Investigational Site, Rotterdam, 3021 HC, Netherlands|GSK Investigational Site, Zwaag, 1689 PZ, Netherlands|GSK Investigational Site, Banska Bystrica, 975 17, Slovakia|GSK Investigational Site, Bratislava, 813 69, Slovakia|GSK Investigational Site, Martin, 036 59, Slovakia|GSK Investigational Site, Alicante, Spain|GSK Investigational Site, Granada, 18003, Spain|GSK Investigational Site, Madrid, 28035, Spain|GSK Investigational Site, Madrid, 28041, Spain|GSK Investigational Site, Madrid, 28046, Spain|GSK Investigational Site, Madrid, 28047, Spain|GSK Investigational Site, Sagunto/Valencia, 46520, Spain|GSK Investigational Site, Santiago De Compostela, 15705, Spain|GSK Investigational Site, Liverpool, Merseyside, L7 8XP, United Kingdom|GSK Investigational Site, Edinburgh, Midlothian, EH3 9YW, United Kingdom|GSK Investigational Site, Paisley, Renfrewshire, PA2 9PN, United Kingdom|GSK Investigational Site, Bath, Somerset, BA1 3NG, United Kingdom|GSK Investigational Site, Livingston, West Lothian, EH54 6PP, United Kingdom|GSK Investigational Site, Gateshead, NE9 6SX, United Kingdom|GSK Investigational Site, Newport, PO30 5TG, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00500955

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D116 Rosiglitazone small molecule DB00412 Details